Low Dose Vaccine Study for Surgically Resected Pancreatic Cancer
Clinical trial NCT00614601 · TERMINATED
Trial details
- NCT number
- NCT00614601
- Sponsor
- NewLink Genetics Corporation
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2008-01-01
- Primary completion
- 2010-05-01
- Enrollment
- 9
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.